BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33361741)

  • 1. Kinesin Family Member C1 (KIFC1) Regulated by Centrosome Protein E (CENPE) Promotes Proliferation, Migration, and Epithelial-Mesenchymal Transition of Ovarian Cancer.
    Li J; Diao H; Guan X; Tian X
    Med Sci Monit; 2020 Dec; 26():e927869. PubMed ID: 33361741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.
    Pawar S; Donthamsetty S; Pannu V; Rida P; Ogden A; Bowen N; Osan R; Cantuaria G; Aneja R
    J Ovarian Res; 2014; 7():53. PubMed ID: 25028599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
    Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
    Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
    Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
    Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.
    Mittal K; Choi DH; Klimov S; Pawar S; Kaur R; Mitra AK; Gupta MV; Sams R; Cantuaria G; Rida PCG; Aneja R
    J Ovarian Res; 2016 Mar; 9():17. PubMed ID: 26992853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
    Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 8. Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis.
    Xie W; Zhang L; Shen J; Lai F; Han W; Liu X
    BMC Cancer; 2024 May; 24(1):551. PubMed ID: 38693472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIFC1 aggravates non-small-cell lung cancer cell proliferation and metastasis via provoking TGF-β/SMAD signal.
    Liu Y; Ye W; Miao X; Wang X
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):293-299. PubMed ID: 38279416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression.
    Jin W; Ye L
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-635 targets KIFC1 to inhibit the progression of gastric cancer.
    Cao FY; Zheng YB; Yang C; Huang SY; He XB; Tong SL
    J Investig Med; 2020 Dec; 68(8):1357-1363. PubMed ID: 32753405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 induced neuroblastoma cell migration and invasion via activation of CENPE/FOXM1 signaling pathway.
    Wang J; Dai W; Zhang M
    Int J Neurosci; 2024 May; 134(5):530-542. PubMed ID: 36168932
    [No Abstract]   [Full Text] [Related]  

  • 14. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 15. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
    Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
    Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIFC1 is a novel potential therapeutic target for breast cancer.
    Li Y; Lu W; Chen D; Boohaker RJ; Zhai L; Padmalayam I; Wennerberg K; Xu B; Zhang W
    Cancer Biol Ther; 2015; 16(9):1316-22. PubMed ID: 26177331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
    Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
    J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.
    Xin L; Zhao R; Lei J; Song J; Yu L; Gao R; Ha C; Ren Y; Liu X; Liu Y; Yao Z; Yang J
    FASEB J; 2019 Mar; 33(3):3795-3806. PubMed ID: 30509125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.